Hongwei Cui
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Circular RNAs in diseases 5
- Histone Deacetylase Inhibitors Research 3
- RNA modifications and cancer 3
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 6
- Cancer, Lipids, and Metabolism 4
- Co-authors
- Xiulan Su (9 shared papers)Xiulan Su (6 shared papers)Wenyan Han (2 shared papers)Junqing Liang (1 shared paper)Minhui Li (3 shared papers)Yongping Mu (2 shared papers)Zhong Chen (1 shared paper)Chao Dong (2 shared papers)
- Journals
- Journal of Cancer (4 papers)Plants (2 papers)Energy Technology (1 paper)Applied Sciences (1 paper)Archives of Dermatological Research (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hongwei Cui
53 papers receiving 590 citations
Peers
Comparison fields: 5 of 112
- Cancer Research 120
- Pharmacology 30
- Molecular Biology 236
- Genetics 28
- Oncology 66
Countries citing papers authored by Hongwei Cui
This map shows the geographic impact of Hongwei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Cui more than expected).
Fields of papers citing papers by Hongwei Cui
This network shows the impact of papers produced by Hongwei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Cui. The network helps show where Hongwei Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongwei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 57 | |
| 2 | 2022 | 52 | |
| 3 | 2020 | 37 | |
| 4 | 2016 | 37 | |
| 5 | 2023 | 28 | |
| 6 | 2017 | 28 | |
| 7 | 2014 | 26 | |
| 8 | 2010 | 23 | |
| 9 | 2015 | 19 | |
| 10 | MiR-5692a promotes proliferation and inhibits apoptosis by targeting HOXD8 in hepatocellular carcinoma. | 2019 | 19 |
| 11 | 2022 | 17 | |
| 12 | 2019 | 17 | |
| 13 | 2023 | 15 | |
| 14 | 2014 | 15 | |
| 15 | 2024 | 14 | |
| 16 | 2019 | 14 | |
| 17 | 2020 | 13 | |
| 18 | 2022 | 12 | |
| 19 | 2011 | 12 | |
| 20 | 2019 | 12 |
About Hongwei Cui
Hongwei Cui is a scholar working on Molecular Biology, Cancer Research, Oncology, Hardware and Architecture and Electrical and Electronic Engineering, having authored 59 papers that have together received 599 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers), Cancer, Lipids, and Metabolism (4 papers), Drilling and Well Engineering (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Parallel Computing and Optimization Techniques (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (120 citations), Pharmacology (30 citations), Molecular Biology (236 citations), Genetics (28 citations) and Oncology (66 citations). Hongwei Cui has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiulan Su, Xiulan Su, Wenyan Han, Junqing Liang, Minhui Li, Yongping Mu, Zhong Chen, Chao Dong, Liya Su and Jialing Zhang. Their work appears in journals such as Journal of Cancer, Plants, Energy Technology, Applied Sciences and Archives of Dermatological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.